Itafos Inc. announced third-quarter adjusted EBITDA of $50.7 million on revenues of $153.2 million, above the year-ago adjusted $41.2 million and $103.0 million, respectively, while reporting lower net income for the period at $8.1 million, 49.7% below $15.7 million in the prior year.
The company cited historic strength in the NOLA DAP market, noting a 22% year-over-year average price increase to $761/st for the quarter, compared to $624/st in 3Q 2021, primarily attributing its third-quarter revenue boost to the company’s Conda integrated phosphate production facility. The company also noted reduced losses due to the February restart of operations at its 220,000 mt/y Arraias sulfuric acid plant in Brazil (GM Feb. 11, 2022).
“The increase in the company’s 3Q 2022 financial performance compared to 3Q 2021 was primarily due to higher realized prices and sales volumes at Conda, which were partially offset by higher input costs,” the company said. “The decrease in net income was primarily due to higher finance and income tax expenses.”
Itafos reported total 3Q capex spend at $8.7 million, up 16% from $7.5 million, attributing the increase to both Conda maintenance and expenditures related to the Arraias restart.
“We are pleased to report continued strong safety, financial, and operational performance during the third quarter,” said Itafos CEO G. David Delaney. “We recognized … continued strong production out of our Conda facility while achieving company record safety performance.”
The company produced 84,908 mt P2O5 at Conda in the third quarter, down 4.8% from the year-ago 89,220 mt P2O5. Sulfuric acid production at Arraias totaled 32,935 mt, compared to zero mt of production in 3Q 2021.
Itafos also touted a debt refinancing effort completed in the third quarter valued at $200 million, in which lenders advanced the company an $85 million term loan, a $35 million letter of credit, and an $80 million asset-based revolving credit facility (GM Sept. 23, 2022).
“On Sept. 22 we completed a major strategic initiative, refinancing our outstanding debt. The new credit facilities [the company] entered into extend our debt maturity and create more flexibility for the funding of the long-term growth of the business,” Delaney said. “As a result of record financial performance for the nine months ended September 2022, we have made significant progress toward deleveraging our balance sheet. In the first three quarters of 2022, we have reduced net debt by $100 million, resulting in a net leverage ratio of 0.5x at the end of the period.”
The company’s net debt on Sept. 30 was $117.7 million, down from $217.7 million at the end of 2021.
Net income for the nine-month period was $85.4 million on revenues of $458.0 million and $174.6 million adjusted EBITDA, beating the year-ago $27.2 million, $296.5 million, and $95.5 million, respectively. Trailing 12-month adjusted EBITDA was noted at $222.6 million, up 55.2% from $143.4 million at the end of 2021.
The company maintained its full-year 2022 guidance of $210-$230 million for adjusted EBITDA and $100-$105 million for net income. Fourth-quarter guidance was $35-$55 million for adjusted EBITDA and $15-$20 million net income.
Itafos also noted a positive outlook for 2023, expecting the current strength in global agriculture and phosphate fertilizer fundamentals to continue, with continued durability in pricing and volume fundamentals in the phosphate fertilizer markets through 2023 relative to the first nine months of 2022.
| Conda (thousands $) | 3Q-22 | 3Q-21 | 9M-22 | 9M-21 |
| Production Volume (mt P2O5) | 84,908 | 89,220 | 254,300 | 246,411 |
| Gross Revenues (loss) | 145,274 | 103,005 | 441,744 | 296,463 |
| Net Income (loss) | 29,564 | 28,746 | 126,786 | 67,880 |
| Adjusted EBITDA (loss) | 54,242 | 45,864 | 185,346 | 107,733 |
| Operating Income (loss) | 45,589 | 39,363 | 163,688 | 89,393 |
| Arraias (thousands $) | 3Q-22 | 3Q-21 | 9M-22 | 9M-21 |
| Production Volume (mt sulfuric acid) | 32,935 | 0 | 63,135 | 0 |
| Net Income (loss) | (684) | (435) | (2,188) | (2,255) |
| Adjusted EBITDA (loss) | 182 | (926) | (66) | (2,698) |
| Operating Income (loss) | (364) | (1,039) | (1,529) | (3,039) |